VYNE THERAPEUTICS INC.

Profile

Company Names

VYNE THERAPEUTICS INC.
MENLO THERAPEUTICS, INC.
TIGERCAT PHARMA, INC.

Addresses

685 ROUTE 202/206 N., SUITE 301, BRIDGEWATER, NJ 08807

685 ROUTE 202/206, SUITE 301A, BRIDGEWATER, NJ 08807

4085 CAMPBELL AVENUE, SUITE 200, MENLO PARK, CA 94025

400 OYSTER POINT BOULEVARD SUITE 202, SOUTH SAN FRANCISCO, CA 94080

Phone Numbers

800-775-7936
650-486-1416
650-745-8179

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

2011

State Incorporated:

DELAWARE

Total Amount Raised:

$139,451,509.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2023-11-01 
$88,151,508.00 
$88,151,508.00 
$0.00 
Equity 
3
2022-11-14 
$300,000.00 
$300,000.00 
$0.00 
Equity 
2
2017-07-14 
$50,500,001.00 
$50,500,001.00 
$0.00 
Equity 
1
2012-12-21 
$500,000.00 
$15,000,000.00 
$14,500,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SHARON 
 
BARBARI 
DIRECTOR
VYNE THERAPEUTICS INC.
STEVEN 
 
BASTA 
DIRECTOR
CARBYLAN BIOSURGERY, INC   |  VIVEVE MEDICAL, INC.   |  DERMBIONT, INC.   |  VYNE THERAPEUTICS INC.
STEVEN 
L. 
BASTA 
EXECUTIVE OFFICER, DIRECTOR
CARBYLAN THERAPEUTICS, INC.   |  MENLO THERAPEUTICS, INC.
ANTHONY 
 
BRUNO 
DIRECTOR
ACFP ACQUISITION HOLDING COMPANY, LLC   |  TRENDKITE, INC.   |  TRENDKITE INC.   |  BLONDER TONGUE LABORATORIES INC   |  ATHLIANCE HOLDINGS, INC.   |  VYNE THERAPEUTICS INC.
ALBERT 
 
CHA 
DIRECTOR
NEOMEND INC   |  VICEPT THERAPEUTICS, INC.   |  TRIA BEAUTY, INC.   |  HEALTH360, INC.   |  YAUPON THERAPEUTICS INC   |  MEDLEY HEALTH, INC.   |  AIRXPANDERS INC   |  VIVO VENTURES VII AFFILIATES FUND, L.P.   |  CEPTARIS THERAPEUTICS, INC   |  ACLARIS THERAPEUTICS, INC.   |  CARBYLAN BIOSURGERY, INC   |  PRONAI THERAPEUTICS INC   |  MINERVA SURGICAL INC   |  CARBYLAN THERAPEUTICS, INC.   |  ASCENDIS PHARMA A/S   |  VIVO CAPITAL FUND VIII, L.P.   |  VIVO CAPITAL SURPLUS FUND VIII, L.P.   |  MENLO THERAPEUTICS, INC.   |  VIVO OPPORTUNITY FUND, L.P.   |  VIVO CAPITAL FUND IX, L.P.   |  VIVO OPPORTUNITY CO-INVEST, L.P.   |  VIVO OPPORTUNITY CO-INVEST (W), L.P.
DAVID 
 
COLLIER 
DIRECTOR
GENESIS TODAY, INC.   |  AUSPEX PHARMACEUTICALS, INC.   |  ARCADIA BIOSCIENCES, INC.   |  ARCION THEREAPEUTICS INC   |  ARCION THERAPEUTICS, INC.   |  SORBENT THERAPEUTICS INC   |  ARDELYX, INC.   |  VERALIGHT INC   |  LDD HOLDINGS, LLC   |  SURGIQUEST INC   |  EXELA HOLDINGS INC   |  REEVE FOUNDATION - PRESIDIO PARTNERS NRT, L.P.   |  MENLO THERAPEUTICS, INC.   |  EIS HOLDCO, LLC
JOHN 
 
CREECY 
DIRECTOR
APOLLO ENDOSURGERY INC   |  MIRAGEN THERAPEUTICS INC   |  BI02 MEDICAL, INC.   |  VUCOMP INC   |  PELOTON THERAPEUTICS, INC.   |  BIOPTIX DIAGNOSTICS, INC.   |  MIRAGEN THERAPEUTICS, INC.   |  APOLLO ENDOSURGERY US INC   |  MENLO THERAPEUTICS, INC.   |  NAVITOR PHARMACEUTICALS, INC.
DAVID 
 
DOMZALSKI 
EXECUTIVE OFFICER, DIRECTOR
VYNE THERAPEUTICS INC.
TED 
 
EBEL 
DIRECTOR
MENLO THERAPEUTICS, INC.
MUTYA 
 
HARSCH 
EXECUTIVE OFFICER
VYNE THERAPEUTICS INC.
JAMES 
 
LARRICK 
EXECUTIVE OFFICER, DIRECTOR
THERON PHARMACEUTICALS, INC.   |  TIGERCAT PHARMA, INC.   |  EUMENTIS THERAPEUTICS, INC.   |  MASCOMA MUTUAL FINANCIAL SERVICES CORP   |  FBOL BANCSHARES, INC.
PATRICK 
 
LEPORE 
DIRECTOR
AGENEBIO, INC.   |  VYNE THERAPEUTICS INC.
KETAN 
 
PATEL 
DIRECTOR
INTELLEFLEX CORP   |  SHOPWELL SOLUTIONS, INC.   |  ACLARIS THERAPEUTICS, INC.   |  RAINMAKER HOLDINGS II, LLC   |  IVENIX, INC.   |  GENOA PHARMACEUTICALS, INC.   |  NFLECTION THERAPEUTICS, INC.   |  MENLO THERAPEUTICS, INC.   |  AMPHORA MEDICAL, INC.   |  FOREST CITY REALTY TRUST, INC.   |  AZAD ALLIANCE 2019 LLC   |  AVALYN PHARMA INC.   |  RALLYBIO HOLDINGS, LLC   |  REDIRECT HEALTH, LLC   |  FOREST CITY ENTERPRISES, L.P.   |  AVIVOMED INC.   |  ABK BIOMEDICAL INC   |  FC 1275 NJ MEMBER LLC   |  FC TOD MF II HOLDINGS LLC   |  FC TOD BTR HOLDINGS I LLC   |  COMANCHE BIOPHARMA CORP.   |  LOS ANGELES BIOSCIENCES, INC.   |  RAINMAKER CAPITAL LLC
ANDREW 
 
PERLMAN 
DIRECTOR
VRINGO INC   |  COSKATA INC   |  TIGERCAT PHARMA, INC.   |  AMP AMERICAS, LLC   |  GREATPOINT VENTURES INNOVATION FUND, L.P.   |  ELM TREE MEDICAL, INC.   |  BOOKMD, INC.   |  GREATPOINT VENTURES INNOVATION PARALLEL FUND, L.P.   |  ONCORESPONSE INC   |  JETTI RESOURCES   |  ROMAINE EMPIRE, INC.   |  FLASH EQUITY LLC   |  GREATPOINT VENTURES INNOVATION FUND II, L.P.   |  GUIDE THERAPEUTICS, INC.   |  EXTEND, INC.   |  DRIVE MEDIA INC.   |  SPRINGCOIN, INC.   |  GPV VIM ACQUISITION COMPANY, LLC   |  INVICTA MEDICAL, INC.   |  SIRONA MEDICAL, INC.   |  RECURRENT VENTURES LLC   |  MYTHIC INC.   |  BIOBOT ANALYTICS, INC.
AARON 
 
ROYSTON 
DIRECTOR
IMPEL NEUROPHARMA INC   |  MENLO THERAPEUTICS, INC.   |  HARMONY BIOSCIENCES II, INC.   |  AKERO THERAPEUTICS, INC.   |  VENBIO GLOBAL STRATEGIC FUND III, L.P.   |  SWIFT HEALTH SYSTEMS INC.   |  RAYZEBIO, INC.   |  VENBIO GLOBAL STRATEGIC FUND IV, L.P.   |  VENTYX BIOSCIENCES, INC.   |  NEUROGASTRX, INC.   |  MAREA THERAPEUTICS, INC.   |  VENBIO GLOBAL STRATEGIC FUND V, L.P.   |  ARPEGGIO BIOSCIENCES, INC.   |  CALDERA THERAPEUTICS, INC.
ELISABETH 
 
SANDOVAL 
DIRECTOR
ALDER BIOPHARMACEUTICALS INC   |  ALASTIN SKINCARE, INC.   |  VYNE THERAPEUTICS INC.
EDWARD 
 
SCHNIPPER 
DIRECTOR
BIND BIOSCIENCES INC   |  SPITFIRE PHARMA, INC.   |  TIGERCAT PHARMA, INC.   |  NEOS THERAPEUTICS, INC.   |  BLUECAVA, INC.
IAIN 
 
STUART 
EXECUTIVE OFFICER
VYNE THERAPEUTICS INC.
SCOTT 
 
WHITCUP 
DIRECTOR
MENLO THERAPEUTICS, INC.   |  ANIVIVE LIFESCIENCES, INC.   |  ADVERUM BIOTECHNOLOGIES, INC.
TYLER 
 
ZERONDA 
EXECUTIVE OFFICER
VYNE THERAPEUTICS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-11-16
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-11-01 
2022-11-18
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-11-14 
2017-07-28
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-07-14 
2013-01-07
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-12-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LIFESCI CAPITAL LLC
168404